COX-2 inhibitors in the treatment of cardiovascular disease

JC Peterson - CMAJ, 2002 - Can Med Assoc
In their report on accelerated publication in medical journals, 1 William Ghali and colleagues
were apparently not asked to update their citation counts beyond December 1999, although …

Cardiovascular risks of COX-2 inhibitors

A Barbier - Trends in Pharmacological Sciences, 2001 - cell.com
Are you a young academic with your eye on a tenured position? Don't count on your older
colleagues retiring soon. A new study by the National Bureau of Economic Research found …

Lessons learned from the COX-2 advisory hearings

J Somberg - American Journal of Therapeutics, 2005 - journals.lww.com
The controversy of increased cardiovascular risk allegedly associated with some or all of the
COX-2 inhibitors recently lead to the convening of an FDA advisory panel. The atmosphere …

[HTML][HTML] Keynote Address: COX-2 Inhibitors

RC Becker - Texas Heart Institute Journal, 2005 - ncbi.nlm.nih.gov
am by training a clinician-scientist in the fields of cardiology, vascular biology and
hematology. In regard to being on “one side of the fence” or the “other” of the COX-2 inhibitor …

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

R Jaeschke, P Gajewski, J Brozek - Circulation, 2002 - Am Heart Assoc
As editors of a journal devoted to the promotion of evidencebased medicine, we search for
and abstract the most relevant (valid and clinically important) reports originally published in …

[CITATION][C] COX 2 inhibitors may increase risk of heart attack

S Gottlieb - Life - europepmc.org
In this article by Anne Gulland (18 August, p 358), owing to a misunderstanding, we said that
the private health insurer PPP has part ownership of some independent hospitals in London …

[CITATION][C] Dear Readers We hope you have enjoyed the range of articles published in the American Journal of Cardiovascular Drugs this year. We have included …

P Amarenco, H Bult, SD Anker, AP Burke… - Am J Cardiovasc …, 2003 - Springer
• Drugs ranked number 4 in the ScienceWatch list of top pharmacology and toxicology
journals of the decade (1992–2002). For this ranking, ScienceWatch used ISI data to …

Risk of cardiovascular events associated with selective COX-2 inhibitors

D Mukherjee, SE Nissen, EJ Topol - Jama, 2001 - jamanetwork.com
Atherosclerosis is a process with inflammatory features and selective cyclooxygenase 2
(COX-2) inhibitors may potentially have antiatherogenic effects by virtue of inhibiting …

COX-2 Inhibitors–Is there cause for concern?

K Seibert, J Lefkowith, C Tripp, P Isakson… - Nature medicine, 1999 - nature.com
COX-2 Inhibitors – Is there cause for concern? | Nature Medicine Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …

[CITATION][C] The COX-2 report: the good, the bad, and the unknown

MR Griffin - JCOM-WAYNE PA-, 2000 - JOURNAL OF CLINICAL …